Variable
|
T0
|
2s
|
3s
|
4s
|
5s
|
6s
|
7s
|
8s
|
9s
|
T1
|
T2
|
T3
|
---|
HAMD
|
X
| | | | | | | | |
X
|
X
| |
FIQ
|
X
| | | | | | | | |
X
|
X
|
X
|
0-100 mm VAS
|
X
| | | | | | | | |
X
|
X
|
X
|
SF12
|
X
| | | | | | | | |
X
|
X
|
X
|
Genogram
|
X
| | | | | | | | | | | |
Tender points count
|
X
| | | | | | | | |
X
|
X
|
X
|
Pain threshold
|
X
| | | | | | | | |
X
|
X
|
X
|
Improvement perceived by patient
| | | | | | | | | |
X
| | |
Expectations and credibility
| | |
X
| | | | | | |
X
| | |
Side effects
| | | | | | | | | |
X
| | |
Diagnosis by traditional Chinese medicine
|
X
| | | | | | | | |
X
| | |
Medication consumed
|
X
| | | | | | | | |
X
| | |
Occupational data
|
X
| | | | | | | | |
X
|
X
|
X
|
Sociodemographic data
|
X
| | | | | | | | | | | |
- VAS: Pain intensity measured on a visual analogue scale; HAMD: Hamilton scale; FIQ: Fibromyalgia Impact Questionnaire; T0: Baseline value; T1: Final value (10 weeks after start of treatment); T2: Follow-up evaluation 1 (6 months after start of treatment); T3: Follow-up evaluation 2 (12 months after start of treatment); #s: Session number.